Will Breakthroughs in Key States Power FuelCell Energy Growth

Trade Idea of The Day Buy SAVA Stock on Dips as its Phase 3 Trial Moves Along Is the recent pullback in Cassava Sciences a sign that it’s time to give up on this risky biotech play? Or, is it an opportunity to enter and/or add to a position in SAVA stock, at a more favorable price? I would say the latter. Yes, this is a very speculative stock. If it fails to make further progress with its Alzheimer’s treatment… Read More

Market News 3 Crypto Moonshots to Get Ahead of the ‘Next Big Thing’ You’ve heard all these buzzwords before. And you’re probably bored of them by now. Tesla has been around since 2003 and 5G technology was invented almost a decade ago. Meanwhile, quantum computing has been the “next big thing” ever since I can remember. But there’s one Moonshot I bet you’re still wondering about: Read More Consider Ford as a Bet on Its Outstanding International Sales Quick: if you had to pick one automotive business to invest in for a lifetime, what would it be? Ford Motor is as valid a response as any. For many generations, F stock has provided reliable returns. Don’t get me wrong — there have been rough patches along the way. The obstacle that’s top-of-mind for many of today’s investors is… Read More Breakthroughs in Key States Will Power FuelCell Energy’s Growth As the world moves towards cleaner power sources, FuelCell Energy is one of the most ambitious providers of environmentally friendly fuel cell systems. At the same time, FCEL stock is still surprisingly affordable. Admittedly, the share-price bump of January and February may have been an instance of “too far, too fast.” So, the stock… Read More

News You May Have Missed Better Options For Bigger Profits! In this market, we’ve got a lot of options… Not all of them good. But our goal here is to make sure to consistently provide you with the best possible picks and options in the market. And this week, you do. Here’s the menu of profit opportunities at Market Traders Daily. Read More Medical Device Company Sees CEO Purchase Shares Out Of The Blue We just spotted a hot new biotech opportunity. This company’s developing a MUCH cheaper alternative to a $10-$15k voluntary medical procedure. Based on my team’s research, it’s potentially just as effective. Exciting stuff, but that alone isn’t why we’re looking at the company. After all, someone could develop a drug or medical treatment… Read More

Disclaimer:Futures, forex, stock, and options trading are not appropriate for all traders. There is a substantial risk of loss associated with trading these markets. Losses can and will occur. No system or methodology has ever been developed that can ensure returns or against losses. No representation or implication is being made that using any of these methodologies or systems will generate returns or ensure against losses.

If you wish to stop receiving our emails or change your subscription options, please Manage Your Subscription
Global Profit Systems International, 15502 Stoneybrook West Parkway Suite 104-153, Winter Garden, FL 34787, US